HD Biosciences, a WuXi AppTec company, is a prominent biology-focused contract research organization (CRO) specializing in plate-based assay development, high-throughput screening (HTS), leading lead optimization, and in vivo pharmacology. Their comprehensive drug discovery platform accelerates small molecule and biologic therapeutics across oncology, immunology, and metabolic disease pathways.